Erba Mannheim Group
About the Founder
Mission and Quality
Research & Development
Awards and Recognitions
ISO 13485 Certificate
ISO 9001 Certificate
Media & Events
Life at Transasia
Media & Events
Our participation in various global symposiums and events, gives us an opportunity to showcase to the world the entire gammut of products we offer. At Transasia Bio-Medicals Ltd., we encourage regular interactions with our business associates and partners, through seminars and conferences.
Some introduction text for Bichemistry products, industries it can be used, company’s vision regarding this product and future plans. Ideally we should have some content here for this
Select Your Country
India - Transasia Bio-Medicals Ltd.
USA - Erba Diagnostics, Inc.
USA - Diamedix Corporation
USA - ImmunoVision, Inc.
USA - JAS Diagnostics Inc.
USA - Drew Scientific
Italy - Delta Biologicals, s.r.l.
Czech Republic - Erba Lachema s.r.o
Russia - Erba Rus
France – Erba Diagnostics France SARL
Turkey - Erba DDS
You are here |
Media & Events
9 JUL 2009
Transasia Bio-Medicals Ltd.,India’s Largest Clinical Diagnostic Co. acquires a leading European diagnostic company.
| Lachema Media Coverage |
| Lachema Factory |
TRANSASIA BIO-MEDICALS LTD., India’s largest clinical diagnostic company has acquired Pliva Lachema Diagnostika, a 42 year old company located in Czech Republic
PLIVA Lachema Diagnostika, is engaged in the development, production and marketing of In Vitro Diagnostics products consisting of a range for
Urine analysis, Biochemistry and Microbiology.
The company, with its extensive marketing and distribution network in the countries of Central and Eastern Europe adequately complements the current market potential and product lines of Transasia and Erba Mannheim. It has state-of-the-art Manufacturing and Research & Development facilities at Brno, employing over 100 people
The acquisition by Transasia through its German subsidiary ERBA Diagnostics Mannheim GmbH, provides a great opportunity for Transasia and ERBA to usher in newer products in the dynamically developing markets of Asia. Also, Lachema’s customers in Central and Eastern Europe will have access to Transasia’s extensive product range in Clinical Chemistry, Immunoturbidimetry and Immunology. Transasia Bio-Medicals Ltd. and ERBA Diagnostics Mannheim plan to invest more than USD 1 Million in Lachema to increase its manufacturing capacities and add new products in the near future for meeting growing demand. This new acquisition greatly expands the spectrum of technologically advanced products and manufacturing capabilities of Transasia. Transasia and ERBA customers will now benefit with these products being offered at high quality and affordable prices.
This acquisition now allows Transasia customers access to a wide range of solutions for microbiology and usher in a quicker and better diagnosis for a range of health issues, which is great news for the Indian healthcare scene. This acquisition will augment the company’s vision of bringing benefits of the best diagnostic technologies within reach for its vast populations in developing countries. The company is a partner of the Clinton foundations Aids control Program in Africa and India.
© Erba Diagnostics
Web / 12 – 2006 / V1 / Dom
Developer : EVTL